ACIP Votes to Expand Recommendation for Pfizer's RSV Vaccine ABRYSVO® to Include Adults Aged 50 to 59 at Increased Risk of Disease Pharmaceutical Investing
Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis Geography
Pfizer Invites Shareholders to Attend Virtual 2025 Annual Meeting of Shareholders on April 24 Pharmaceutical Investing
New York Plastic Surgical Group and Deep Blue Med Spa Receive State and National Recognition by Allergan Aesthetics Pharmaceutical Investing
AbbVie Announces European Commission Approval of RINVOQ® for the Treatment of Adults with Giant Cell Arteritis Pharmaceutical Investing
